Tag: Human Leukocyte Antigen
Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant
Bottom Line: Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time. Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR) […]